Two candidate small interfering RNAs (siRNAs) corresponding to severe acute respiratory
syndrome-associated coronavirus (SARS-CoV) spike gene were designed and in vitro …

SARS-CoV is a newly identified coronavirus that causes severe acute respiratory syndrome
(SARS). Currently, there is no effective method available for prophylaxis and treatment of …

Background Severe acute respiratory syndrome (SARS) is an infectious disease caused by
SARS-CoV. There are no effective antiviral drugs for SARS although the epidemic of SARS …

Small interfering RNA (siRNA) is a class of duplex RNA molecules of 21-25 nt nucleotides in
length functioning post-transcriptionally to downregulate targeted gene expression. The …

The severe acute respiratory syndrome (SARS) has been one of the most epidemic
diseases threatening human health all over the world. Based on clinical studies, SARS-CoV …

The severe acute respiratory syndrome coronavirus (SARS CoV) genome has 14 potential
open reading frames (ORFs). The first ORF is translated from the full-length genomic mRNA …

The spike (S) protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is
important for vaccine development. A truncated S protein of the TW1 strain, STR2 (88kDa) …

Severe acute respiratory syndrome (SARS) is a newly emerged infectious disease caused
by a novel coronavirus (SARS-CoV), which spread to over 30 countries in early 2003. Until …

In March 2003, a novel coronavirus was isolated from patients exhibiting atypical
pneumonia and subsequently proven to be the causative agent of the disease now referred …

Abstract Background SARS coronavirus (SARS-CoV) is the etiologic agent of the severe
acute respiratory syndrome. SARS-CoV mainly infects tissues of non-lymphatic origin, and …